David Chan
University of Sydney/Royal North Shore hospital, NSW, Australia
David Chan is a medical oncologist based at the Royal North Shore Hospital. After completing training, he undertook a neuroendocrine tumour fellowship at Sunnybrook Hospital, Toronto, Canada, after having completed oncology training.
He is currently completing his PhD at the University of Sydney and his thesis is entitled: “Dual PET Imaging in Neuroendocrine Tumours”. He has authored over 25 peer-reviewed publications in NETs to date. David’s research interests include imaging-based
biomarkers for NETs (particularly PET imaging), systematic reviews and clinical trial design.
Presentations this author is a contributor to:
The Lymphocyte-to-Monocyte ratio is a superior predictor of OS in comparison to established biomarkers in CRC patients undergoing curative resection. (#19)
11:15 AM
Joseph Chan
Best of the Best Orals - Clinical research
ALK Translocated Non-Small Cell Lung Cancer: Experience from an Australian metropolitan tertiary referral centre. (#367)
3:00 PM
Malinda Itchins
Posters 2
Neuroendocrine tumor (NET) Oceania patient experience: results from the first global NET patient survey - A collaboration between the International Neuroendocrine Cancer Alliance (INCA) and Novartis (#74)
11:30 AM
John Leyden
Best of the Best Orals - Rare Cancers